24 results
8-K
EX-4.2
BBLNF
Babylon Holdings Ltd
21 Jul 23
Entry into a Material Definitive Agreement
4:31pm
by one or more members of the Group relating to the sale of (i) the Group, (ii) a strategic minority shareholding in any member of the Group … of the the Majority Bridge Noteholders, any acquisition of any shares or securities owned by minority shareholders in members of the Group;
(g)an acquisition
8-K
EX-10.3
BBLNF
Babylon Holdings Ltd
25 May 23
Departure of Directors or Certain Officers
6:01am
&A Process” means a sales process by one or more members of the Group relating to the sale of (i) the Group, (ii) a strategic minority shareholding in any … )the Health Innovators Permitted Acquisition or with the prior consent of the Holder Majority, any acquisition of any shares or securities owned by minority
10-Q
2023 Q1
BBLNF
Babylon Holdings Ltd
10 May 23
Quarterly report
4:07pm
to a recapitalization of the Group and/or the sale of the Group, a sale of a strategic minority stake in the Group or a sale of material assets or subsidiaries
10-Q
2023 Q1
EX-10.3
BBLNF
Babylon Holdings Ltd
10 May 23
Quarterly report
4:07pm
may disclose this Agreement to any of their Connected Persons and to any other minority shareholder of the Company which is not a signatory … to this Agreement, provided that, prior to such disclosure, the relevant Connected Person or minority shareholder is informed of its obligation to keep
10-Q
2023 Q1
EX-4.5
BBLNF
Babylon Holdings Ltd
10 May 23
Quarterly report
4:07pm
Association.
“M&A Process” means a sales process by one or more members of the Group relating to the sale of (i) the Group, (ii) a strategic minority … or with the prior consent of the the Majority Bridge Noteholders, any acquisition of any shares or securities owned by minority shareholders in members
8-K
yxaocgmdeww
10 May 23
Babylon Secures Financing and Plans to Implement a Take Private Transaction with Support from AlbaCore Capital
6:00am
424B3
8r9btz
6 Dec 22
Prospectus supplement
5:22pm
424B3
y9fsen ewpu
5 Dec 22
Prospectus supplement
4:16pm
POS AM
55pprj5ur29w
29 Nov 22
Prospectus update (post-effective amendment)
4:49pm
F-3
4nla6tv8uj74tx5h rz
23 Nov 22
Shelf registration (foreign)
4:17pm
6-K
EX-99.2
fnds yob4zxhfpsuqlt
10 Nov 22
Babylon Reports Another Strong Quarter Ahead of Consensus Estimates with Revenue Growth of 3.9x and 45 ppts Adjusted EBITDA Margin Improvement
6:03am
6-K
EX-99.2
fp5cor53
9 Aug 22
Babylon Again Delivers Strong Performance with Record Margins for Second Quarter 2022
12:00am
6-K
EX-99.2
pq7wja3y6
12 May 22
Babylon Delivers Massive Growth and Adjusted EBITDA Margin Improvement in the First Quarter of 2022 and Raises 2022 Revenue Guidance
6:00am
424B3
xr4umsmnmv d1wh
9 May 22
Prospectus supplement
4:15pm
424B3
ij6eo8ucghk7umpwh6rm
3 May 22
Prospectus supplement
4:16pm
F-1
3kngis1
29 Apr 22
Registration statement (foreign)
5:09pm
POS AM
w49 e8ph24
28 Apr 22
Prospectus update (post-effective amendment)
5:28pm
424B3
835f1fe3ha9q1dh81bkn
30 Mar 22
Prospectus supplement
5:19pm
20-F
EX-2.1
hzg0xo11
30 Mar 22
Annual report (foreign)
4:12pm
20-F
mifz1 i6lbz
30 Mar 22
Annual report (foreign)
4:12pm